简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-10-22 13:58 Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule
2025-10-22 12:43 BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
2025-10-22 10:47 InterSystems and Google Cloud Integrate InterSystems HealthShare with Google Cloud’s Healthcare API
2025-10-22 10:22 Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation
2025-10-22 09:07 Samsung Bioepis And Phrontline Announce a Global Strategic Partnership to Advance Best-in-Class Antibody-Drug Conjugate Therapeutics for Solid Tumors
2025-10-21 15:56 HistoSonics Announces Oversubscribed $250 Million Growth Financing
2025-10-20 14:07 Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO
2025-10-20 13:26 NEL Animal Medical Foundation Brings K-Veterinary Excellence at ASASVC
2025-10-20 10:13 Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
2025-10-17 13:54 New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub
2025-10-17 11:23 Gradiant Secures $50 Million Credit Facility from HSBC, Exceeding $100 Million in Total Financing Capacity
2025-10-14 12:38 BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
2025-10-13 14:13 Pacific Prime Hong Kong Wins Top Producer for SMEs and Top Growth Driver for SMEs Awards from Bupa Global
2025-10-13 11:06 Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO® (rezafungin)
2025-10-11 15:44 Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
2025-10-11 15:32 Tempus Joins Parse Biosciences’ Certified Service Provider Network
2025-10-11 13:19 In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
2025-10-11 10:44 Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions
2025-10-10 15:52 Children's Hospital Los Angeles Recognized Among the United States' Top 10 Children's Hospitals for 17 Consecutive Years
2025-10-10 15:47 Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study

Business Wire Weibo

Press Releases

Latest Releases